Venus Medtech (Hangzhou) Class H Other Current Liabilities

Venus Medtech (Hangzhou) Class H posts a other current liabilities of $140M as of June 2026. That compares with $180M in the prior-year period — down 20.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Venus Medtech (Hangzhou) Class H's other current liabilities was $180M. The latest reading is $140M — a 20.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Other Current Liabilities is one piece of Venus Medtech (Hangzhou) Class H's financial statement story. At $140M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for VMTHF's other current liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Venus Medtech (Hangzhou) Class H's other metric pages and overview cover the third.